IAN T. BOTHWELL - 26 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
26 May 2021
Transactions value $
$-34,843
Form type
4
Filing time
28 May 2021, 21:43:23 UTC
Previous filing
25 May 2021
Next filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $-7,720 -40,000 -0.03% $0.1930 149,128,726 26 May 2021 Direct
transaction OCEL Common Stock Sale $-9,000 -50,000 -0.03% $0.1800 149,078,726 27 May 2021 Direct
transaction OCEL Common Stock Sale $-6,957 -38,650 -0.03% $0.1800 149,040,076 27 May 2021 Direct
transaction OCEL Common Stock Sale $-2,066 -11,350 -0.01% $0.1820 149,028,726 27 May 2021 Direct
transaction OCEL Common Stock Sale $-9,100 -50,000 -0.03% $0.1820 148,978,726 28 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.